Skip to main content
Signal8

MUELLER PETER

SEC insider (Form 3/4/5 filer). CIK 0001256126. Director at BioXcel Therapeutics, Inc. (BTAI). 1 reported Form 4/5 transaction since Sep 2024; latest on Jan 9, 2026. Located in NEW HAVEN, CT.

Companies MUELLER PETER has filed insider reports for

  • BioXcel Therapeutics, Inc. (BTAI): Director
MUELLER PETER profile photo

MUELLER PETER

CIK: 0001256126

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BioXcel Therapeutics, Inc. logo
BTAI

BioXcel Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • BioXcel Therapeutics, Inc. logo
    BTAI

    BioXcel Therapeutics, Inc.

    Jan 9, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    17K shares-

1-1 of 1